Descripción de negocio
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research, development and manufacture.
Consejo de gestión & Consejo de supervisión
| CEO |
| John Dawson |
| Consejo de gestión |
| Stuart Paynter, Helen Stephenson-Ellis, James Miskin, Jason Slingsby, Kyriacos Mitrophanous, Matthew Treagus, Natalie Walter, Nick Page |
| Consejo de supervisión |
| Dr. Roch Doliveux, Dr. Michael Hayden, Dr. Sam Rasty, Heather Preston, John Dawson, Prof. Dame Kay Davies, Robert Ghenchev, Stuart Henderson, Stuart Paynter |
Datos de la empresa
| Nombre: |
Oxford BioMedica plc |
| Dirección: |
Windrush Court, Transport Way,UK-Oxford OX4 6LT |
| Teléfono: |
+44-1865-783-000 |
| Fax: |
+44-1865-783-001 |
| E-mail: |
enquiries@oxfordbiom...a.co.uk
enquiries@oxfordbiomedica.co.uk
|
| Internet: |
https://www.oxb.com/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
50.20% |
| Fecha de OPI: |
- |
